PHASE IB DOSE-ESCALATION STUDY OF BEZ235 OR BKM120 IN COMBINATION WITH PACLITAXEL (PTX) IN PATIENTS WITH ADVANCED SOLID TUMORS

被引：0
|
作者：
Dirix, L. [1 ]
Schuler, M. [2 ]
Machiels, J. [3 ]
Hess, D. [4 ]
Awada, A. [5 ]
Steeghs, N. [6 ]
Paz-Ares, L. [7 ]
von Moos, R. [8 ]
Rabault, B. [9 ]
Rodon, J. [10 ]
机构：
[1] Sint Augustinus Hosp, Antwerp, Belgium
[2] Univ Klinikum Essen, Westdeutsch Tumorzentrum, Essen, Germany
[3] Clin Univ St Luc, Dept Med Oncol, B-1200 Brussels, Belgium
[4] Kantonsspital St Gallen, St Gallen, Switzerland
[5] Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium
[6] Netherlands Canc Inst, Amsterdam, Netherlands
[7] Univ Hosp Virgen del Rocio, Seville, Spain
[8] Kantonsspital Graubunden, Chur, Switzerland
[9] Novartis Pharma AG, Oncol, Basel, Switzerland
[10] Vall dHebron Univ Hosp, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：157 / 158
页数：2
相关论文
共 50 条
  • [1] BEZ235 in combination with everolimus for advanced solid malignancies: Preliminary results of a phase Ib dose-escalation study.
    Salkeni, Mohamad Adham
    Rixe, Olivier
    Karim, Nagla Abdel
    Ogara, Sue
    Feiler, Monica
    Moorthy, Ganesh
    Mercer, Carol A.
    Thomas, Hala
    Desai, Pankaj B.
    Fathallah, Hassana
    Kozma, Sara
    Thomas, George
    Morris, John Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] A DOSE ESCALATION SINGLE ARM PHASE IB COMBINATION STUDY OF BEZ235 WITH EVEROLIMUS IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES
    Wise-Draper, T.
    Moorthy, G.
    Salkeni, M.
    Thomas, H.
    Mercer, C.
    Kozma, S.
    Thomas, G.
    Rixe, O.
    Desai, P.
    Morris, J.
    Olowokure, O.
    ANNALS OF ONCOLOGY, 2015, 26 : 19 - 19
  • [3] Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer
    Massard, Christophe
    Chi, Kim Nguyen
    Castellano, Daniel
    de Bono, Johann
    Gravis, Gwenaelle
    Dirix, Luc
    Machiels, Jean-Pascal
    Mita, Alain
    Gonzalez, Begona Mellado
    Turri, Sabine
    Maier, Joan
    Csonka, Denes
    Chakravartty, Arunava
    Fizazi, Karim
    EUROPEAN JOURNAL OF CANCER, 2017, 76 : 36 - 44
  • [4] A phase I dose-escalation study of buparlisib (BKM120), an oral pan-PI3K inhibitor, in Chinese patients with advanced solid tumors
    Zhang, L.
    Xu, B.
    Hazell, K.
    Gaur, A.
    Xu, J.
    Trandafir, L.
    Wu, Y. L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S185 - S186
  • [5] Phase Ib study of abiraterone acetate (AA) plus buparlisib (BKM120) or BEZ235 in patients (pts) with castration-resistant prostate cancer (CRPC)
    Chi, K.
    Castellano, D.
    De Bono, J.
    Gravis, G.
    Dirix, L.
    Machiels, J. P.
    Mita, A.
    Mellado Gonzalez, B.
    Massard, C.
    Trandafir, L.
    Dey, D.
    Csonka, D.
    Chakravartty, A.
    Fizazi, K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S493 - S493
  • [6] Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors
    Bendell, Johanna C.
    Rodon, Jordi
    Burris, Howard A.
    de Jonge, Maja
    Verweij, Jaap
    Birle, Diana
    Demanse, David
    De Buck, Stefan S.
    Ru, Qinhua C.
    Peters, Malte
    Goldbrunner, Michael
    Baselga, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) : 282 - 290
  • [7] A phase Ib dose-escalation study of TRC105 in combination with bevacizumab for advanced solid tumors
    Mendelson, David S.
    Rosen, Lee S.
    Robert, Francisco
    Chiorean, E. Gabriela
    Goldman, Jonathan Wade
    Seon, Ben K.
    Alvarez, Delia
    Adams, Bonne J.
    Theuer, Charles P.
    Leigh, Bryan R.
    Gordon, Michael S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Phase I/Ib dose-escalation study of aveluma in Chinese patients with advanced solid tumors
    Wu, Yi-Long
    Cheng, Ying
    Chen, Huajun
    Tu, Haiyan
    Xu, Chongrui
    Wang, Zhen
    Liu, Ying
    Xin, Ying
    Lou, Haizhou
    Wang, Wei
    Chin, Kevin
    Li, Dandan
    Zhao, Di
    Gao, Yanfei
    Xu, Wenping
    Pan, Hongming
    FUTURE ONCOLOGY, 2022,
  • [9] Phase I/Ib dose-escalation study of avelumab in Chinese patients with advanced solid tumors
    Wu, Yi-Long
    Cheng, Ying
    Chen, Huajun
    Tu, Haiyan
    Xu, Chongrui
    Wang, Zhen
    Liu, Ying
    Xin, Ying
    Lou, Haizhou
    Wang, Wei
    Chin, Kevin
    Li, Dandan
    Zhao, Di
    Gao, Yanfei
    Xu, Wenping
    Pan, Hongming
    FUTURE ONCOLOGY, 2022, 18 (17) : 2053 - 2062
  • [10] A dose-finding phase Ib study of BEZ235 in combination with paclitaxel in patients with HER2-negative, locally advanced or metastatic breast cancer
    Gil-Martin, M.
    Fumoleau, P.
    Isambert, N.
    Urruticoechea, A.
    Beck, J. T.
    Csonka, D.
    di Tomaso, E.
    Gaur, A.
    Roiffe, K.
    Urban, P.
    Vincent, G.
    Campone, M.
    CANCER RESEARCH, 2013, 73
12345